- Product Details
Keywords
- 1-(1,2-Benzoxazol-3-yl)methanesulphonamide
- anti-convulsant
Quick Details
- ProName: zonisamide
- CasNo: 68291-97-4
- Molecular Formula: C8H8N2O3S
- Appearance: white powder
- Application: anti-convulsant agent
- DeliveryTime: 2 weeks
- PackAge: 25kg/drum
- ProductionCapacity: 1 Metric Ton/Month
- Purity: 99%
- Storage: room temperature
- Transportation: below 40 degree celsius
- LimitNum: 1 Kilogram
- Related Substances: 0.5% max.
- Heavy Metal: 20ppm max
Superiority
Synonyms: 1-(1,2-Benzoxazol-3-yl)methanesulphonamide
Main Specifications:
Appearance: white crystalline powder
Assay: 99% Min. HPLC
Single Impurity: 0.5% Max.
Loss on Drying: 0.5% Max.
Heavy Metal: 20ppm Max.
Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunct therapy in adults with partial-onset seizures. Zonisamide is approved in the United States, United Kingdom, China, for adjunctive treatment of partial seizures in adults and in Japan for both adjunctive and monotherapy for partial seizures (simple,complex, secondarily generalized), generalized (tonic, tonic-clonic(grand mal), and atypical absence) and combined seizures.